MED on NYSE

Medifast

Logo: Medifast, Public domain, via Wikimedia Commons4

American multi-level marketing company

Medifast, Inc. (NYSE: MED) is an American nutrition and weight loss company based in Baltimore, Maryland.3 From Wikipedia, CC BY-SA 4.0

Price unavailable

Last updated Oct 18, 2026.

Overview

1980Founded1

Compare with Farmer Brothers, Utz Brands or COFFEE HOLDING CO INC, or pick any stock.

  • TickerMED on NYSE1
  • IndustryMiscellaneous Food Preparations & Kindred Products1
  • HeadquartersBaltimore1
  • Websitewww.medifast1.com
  • Incorporated inDE5
  • Business address1501 S. Clinton Street, Suite 500, Baltimore, Md 212245
  • Filer categoryAccelerated filer, Smaller reporting company5

Medifast, Inc. (NYSE: MED) is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

71.3%Gross margin7
-3.7%Operating margin7
-4.8%Net margin7
-36.0%Revenue growth, 20257
-9.4%Return on equity7
$1.2MFree cash flow7

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue27¢$110.6M
  • Research and development1¢$4.3M
  • Selling, general and admin69¢$289.4M
  • Income tax3¢$13.0M

Out of $385.8M in revenue.7 The company lost money this year.

Where each dollar of operating cash went, fiscal 2025

  • Capital spending82¢$5.6M
  • Dividends paid3¢$195.0K
  • Kept or used elsewhere15¢$1.1M

Out of $6.9M of cash from operations.7

Financial statements

Revenue89107$385.8M in 2025−46% since 2019
0$500.0M$1.0B$1.5B$2.0B2019: $713.7M$713.7M20192020: $934.8M$934.8M2020+31%2021: $1.5B$1.5B2021+63%2022: $1.6B$1.6B2022+5%2023: $1.1B$1.1B2023−33%2024: $602.5M$602.5M2024−44%2025: $385.8M$385.8M2025−36%
Gross profit11129107$275.2M in 2025−49% since 2019
0$500.0M$1.0B$1.5B2019: $536.9M$536.9M20192020: $697.8M$697.8M2020+30%2021: $1.1B$1.1B2021+62%2022: $1.1B$1.1B2022+1%2023: $775.9M$775.9M2023−32%2024: $444.6M$444.6M2024−43%2025: $275.2M$275.2M2025−38%
Operating income11129107-$14.2M in 2025
-$100.0M0$100.0M$200.0M$300.0M2019: $91.0M$91.0M20192020: $134.2M$134.2M2020+47%2021: $216.2M$216.2M2021+61%2022: $184.8M$184.8M2022−15%2023: $126.4M$126.4M2023−32%2024: $2.9M$2.9M2024−98%2025: -$14.2M-$14.2M2025
Net income11129107-$18.7M in 2025
-$50.0M0$50.0M$100.0M$150.0M$200.0M2019: $77.9M$77.9M20192020: $102.9M$102.9M2020+32%2021: $164.0M$164.0M2021+59%2022: $143.6M$143.6M2022−12%2023: $99.4M$99.4M2023−31%2024: $2.1M$2.1M2024−98%2025: -$18.7M-$18.7M2025

Every line of the income statement as filed: the last 3 fiscal years, latest first.7

Period ending2025-12-312024-12-312023-12-31
Revenue$385.8M$602.5M$1.1B
Cost of sales$110.6M$157.8M$296.2M
Gross profit$275.2M$444.6M$775.9M
Selling, general, and administrative$289.4M$441.7M$649.4M
Income (loss) from operations-$14.2M$2.9M$126.4M
Interest income$5.5M$4.8M$2.5M
Other income (expense)$3.1M-$3.9M-$95.0K
Total other income (expense)$8.6M$909.0K$2.4M
Income (loss) before provision for income taxes-$5.6M$3.8M$128.8M
Income Tax Expense (Benefit)$13.0M$1.7M$29.4M
Net income (loss)-$18.7M$2.1M$99.4M
Basic (in usd per share)-$1.70$0.19$9.13
Diluted (in usd per share)-$1.70$0.19$9.10
Basic (in shares)11.0M shares10.9M shares10.9M shares
Diluted (in shares)11.0M shares11.0M shares10.9M shares
Cash dividends declared per share (in usd per share)$0.00$0.00$4.95

Compare Medifast with another company

The story

William Vitale, a medical doctor, founded Medifast in 1980. He sold his products directly to other doctors, who in turn prescribed them to their patients alongside behavioural counselling techniques.

The company is publicly traded on the New York Stock Exchange (symbol: MED).

On July 17, 1995, HealthRite (predecessor of Medifast) changed its name from Vitamin Specialties Corp.

In 2000 the company pivoted to a direct-to-consumer marketing program with the help of Jason Pharmaceuticals and in 2001, the company changed its name to Medifast, Inc. In 2002, Retired Marine Colonel Bradley T. MacDonald, Chairman of the Board at the time, along with clinical specialist Dr. Wayne Scott Andersen, created Take Shape For Life as a personal Coach to the Client system and the company's “Habits of Health System.”

In October 2010, Medifast was ranked number 1 on Forbes magazine's list of "America's 100 Best Small Companies". The company was ranked 18th on the 2014 list.

Medifast was named one of Forbes's 100 Most Trustworthy Companies in America in 2016 and 2017.

In July 2017, Medifast changed the name of its subsidiary Take Shape For Life to Optavia and introduced a new line of products, Optavia Essentials, directly sold from Coaches to clients.

In October 2017, Medifast relocated its headquarters to Baltimore from Owings Mills, Maryland. The company is public with a market capitalization of $2.106 billion, as of June 2022.

Read the full text

In December 2023, Medifast announced a partnership with LifeMD, a provider of virtual healthcare services. Under the agreement, Medifast will use LifeMD's virtual platform to offer Medifast clients a clinically supported weight management program, including the option for prescription GLP-1 medications where clinically appropriate. In return, LifeMD will provide its patients with an independent Medifast Coach and additional lifestyle support services for weight management.

From Wikipedia’s article on Medifast, shared under CC BY-SA 4.0.6

Leadership

Who has led Medifast, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (44)

Products and brands

The company owns five subsidiaries:

Jason Pharmaceuticals, Inc.

Take Shape for Life, Inc. (TSFL) (renamed Optavia from July 2017)

Jason Enterprises, Inc.

Read the full text

Jason Properties, LLC

Seven Crondall, LLC

From Wikipedia’s article on Medifast, shared under CC BY-SA 4.0.6

Subsidiaries and ownership

Subsidiaries

  • OPTAVIA, LLC

From Wikidata.1

Former names

  • HEALTHRITE INCAug 14, 1996 to Jan 9, 20015

Timeline

  1. Oct 4, 2016New chief executive Daniel R. Chard becomes CEO15
  2. Jun 19, 2014New chief executive Michael C. Macdonald becomes CEO16
  3. Aug 26, 2009New chief executive Michael S. McDevitt becomes CEO17
  4. May 18, 2006New chief executive Brazdley T. Macdonald becomes CEO18
  5. Dec 20, 2002Went public Listed on NYSE1
  6. 1980Founded Founded1

Filings

240 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 41 major events, 119 insider forms, 31 large holders, 29 other. The latest 20:

  1. Sep 30, 20264 EDGAR
  2. Sep 29, 2026144 EDGAR
  3. Sep 28, 2026144 EDGAR
  4. Aug 28, 20264 EDGAR
  5. Aug 26, 20264 EDGAR
  6. Aug 21, 2026SCHEDULE 13D/A EDGAR
  7. Aug 21, 20264 EDGAR
  8. Aug 14, 2026SCHEDULE 13G EDGAR
  9. Aug 14, 2026SCHEDULE 13G/A EDGAR
  10. Aug 12, 2026SCHEDULE 13G/A EDGAR
  11. Aug 3, 2026S-8 EDGAR
  12. Aug 3, 202610-Q EDGAR
  13. Aug 3, 20268-K EDGAR
  14. Jul 29, 2026SCHEDULE 13G/A EDGAR
  15. Jul 17, 20268-K EDGAR
  16. Jul 10, 20263/A EDGAR
  17. Jun 1, 20268-K EDGAR
  18. May 28, 20264 EDGAR
  19. May 28, 20264 EDGAR
  20. May 28, 20264 EDGAR

The 240 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 31 such filings since October 2021, the latest 10:

  1. Aug 21, 2026SCHEDULE 13D/A
  2. Aug 14, 2026SCHEDULE 13G
  3. Aug 14, 2026SCHEDULE 13G/A
  4. Aug 12, 2026SCHEDULE 13G/A
  5. Jul 29, 2026SCHEDULE 13G/A
  6. May 15, 2026SCHEDULE 13G
  7. May 14, 2026SCHEDULE 13G/A
  8. May 14, 2026SCHEDULE 13G/A
  9. Mar 27, 2026SCHEDULE 13G/A
  10. Mar 20, 2026SCHEDULE 13D

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Renaissance Technologies LLC778,610$8.3M0.0%+4,900
Steamboat Capital Partners, LLC706,699$7.5M1.6%−891
Two Sigma Investments, LP481,381$5.1M0.0%+143,223
Vanguard Capital Management LLC446,614$4.7M0.0%+2,147
Charles Schwab Investment Management Inc396,996$4.2M0.0%−234,543
BlackRock, Inc.369,503$3.9M0.0%−574,950
Dimensional Fund Advisors LP363,394$3.9M0.0%+1,632
American Century Companies Inc318,911$3.4M0.0%+94,631
Morgan Stanley292,508$3.1M0.0%−32,804
Goldman Sachs Group Inc243,085$2.6M0.0%+89,914
Marshall Wace, Llp241,649$2.6M0.0%New
Aqr Capital Management LLC236,434$2.5M0.0%+90,859
Peapod Lane Capital LLC222,576$2.4M1.6%+3,513
Lido Advisors, LLC220,337$2.3M0.0%+37,302
Trexquant Investment LP212,684$2.3M0.0%+32,603
Jane Street Group, LLC164,881$1.7M0.0%+38,474
Commons Capital, LLC149,916$1.6M1.1%+111,916
Quinn Opportunity Partners LLC127,112$1.3M0.1%No change
Geode Capital Management, LLC121,071$1.3M0.0%−132,244
Bridgeway Capital Management, LLC117,078$1.2M0.0%−40,000
RBF Capital, LLC109,000$1.2M0.0%New
Jpmorgan Chase & Co92,512$989.9K0.0%+5,334
D. E. Shaw & Co., Inc.92,345$979.8K0.0%−68,219
Bank Of America Corp /de/87,118$924.3K0.0%−1,659
Quantinno Capital Management LP82,997$880.6K0.0%+26,844

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

2 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

DateMemberTradeAmountVs S&P sinceFiling
Jun 24, 2019Donna Shalala, HouseSale$1,001 - $15,000+253.4%Report
Apr 30, 2019Donna Shalala, HouseBuy$1,001 - $15,000−254.3%Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68